KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Exelixis (EXEL) Shares Outstanding (Diluted Average) (2016 - 2026)

Exelixis (EXEL) has 15 years of Shares Outstanding (Diluted Average) data on record, last reported at $281.9 million in Q1 2026.

  • For Q1 2026, Shares Outstanding (Diluted Average) fell 4.82% year-over-year to $281.9 million; the TTM value through Jan 2026 reached $281.9 million, down 4.82%, while the annual FY2026 figure was $281.9 million, 4.82% down from the prior year.
  • Shares Outstanding (Diluted Average) reached $281.9 million in Q1 2026 per EXEL's latest filing, down from $283.7 million in the prior quarter.
  • Across five years, Shares Outstanding (Diluted Average) topped out at $326.8 million in Q2 2023 and bottomed at $281.9 million in Q1 2026.
  • Average Shares Outstanding (Diluted Average) over 5 years is $307.7 million, with a median of $313.5 million recorded in 2023.
  • Peak YoY movement for Shares Outstanding (Diluted Average): rose 0.95% in 2022, then dropped 10.11% in 2024.
  • A 5-year view of Shares Outstanding (Diluted Average) shows it stood at $324.6 million in 2022, then dropped by 0.95% to $321.5 million in 2023, then dropped by 9.33% to $291.5 million in 2024, then decreased by 2.67% to $283.7 million in 2025, then decreased by 0.65% to $281.9 million in 2026.
  • Per Business Quant database, its latest 3 readings for Shares Outstanding (Diluted Average) were $281.9 million in Q1 2026, $283.7 million in Q4 2025, and $286.3 million in Q3 2025.